Biomica to Present at Jefferies Microbiome-Based Therapeutics Summit, on April 22nd, 2021
Biomica, a biopharmaceutical company focused on microbiome-based therapeutics and a subsidiary of Evogene Ltd. (NASDAQ: EVGN), announced that CEO Dr. Elran Haber will present at the Jefferies Microbiome-Based Therapeutics Summit on April 22, 2021. The presentation will highlight Biomica's innovative approaches using a Computational Predictive Biology platform to develop therapies targeting antibiotic-resistant bacteria and gastrointestinal disorders. One-on-one meetings will be available for further discussions during the summit.
- None.
- None.
REHOVOT, Israel, April 19, 2021 /PRNewswire/ -- Biomica Ltd., an emerging biopharmaceutical company developing innovative microbiome-based therapeutics, and a subsidiary of Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), today announced that Dr. Elran Haber, Chief Executive Officer of Biomica, will present at the Jefferies Microbiome-Based Therapeutics Summit being held on Thursday, April 22, 2021.
Dr. Haber will be available for one-on-one meetings during the summit.
A Pre-Recording of the Presentation will be made available on Thursday, April 22, 2021.
About Biomica:
Biomica is an emerging biopharmaceutical company developing innovative microbiome-based therapeutics utilizing a dedicated Computational Predictive Biology platform (CPB), licensed from Evogene. Biomica aims to identify and characterize disease-related microbiome entities and to develop novel therapeutics based on these understandings. The company is focused on the development of therapies for antibiotic resistant bacteria, immuno-oncology, and microbiome-related gastrointestinal (GI) disorders. Biomica is a subsidiary of Evogene Ltd. (NASDAQ: EVGN, TASE: EVGN). For more information, please visit www.biomicamed.com.
Contact:
Rivka Neufeld/ Aviva Banczewski
Investor Relations and Public Relations Manager
E: IR@evogene.com
T: +972-8-931-1900
US Investor Relations:
Joseph Green
Edison Group
E: jgreen@edisongroup.com
T: +1 646-653-7030
Laine Yonker
Edison Group
E: lyonker@edisongroup.com
T: +1 646-653-7035
View original content:http://www.prnewswire.com/news-releases/biomica-to-present-at-jefferies-microbiome-based-therapeutics-summit-on-april-22nd-2021-301271332.html
SOURCE Biomica
FAQ
What date is Biomica presenting at the Jefferies Microbiome-Based Therapeutics Summit?
Who is presenting on behalf of Biomica at the summit?
What is the focus of Biomica's therapeutic development?
Is there an opportunity for one-on-one meetings during the summit?
What platform does Biomica use for its therapeutic development?
